Taiko Pharmaceutical Co.,Ltd.

TSE:4574 Stock Report

Market Cap: JP¥17.6b

Taiko PharmaceuticalLtd Past Earnings Performance

Past criteria checks 0/6

Taiko PharmaceuticalLtd's earnings have been declining at an average annual rate of -44.7%, while the Medical Equipment industry saw earnings growing at 8.2% annually. Revenues have been declining at an average rate of 16.9% per year.

Key information

-44.7%

Earnings growth rate

-44.5%

EPS growth rate

Medical Equipment Industry Growth7.8%
Revenue growth rate-16.9%
Return on equity-53.6%
Net Margin-59.0%
Next Earnings Update10 May 2024

Recent past performance updates

Recent updates

Is Taiko PharmaceuticalLtd (TSE:4574) A Risky Investment?

Mar 08
Is Taiko PharmaceuticalLtd (TSE:4574) A Risky Investment?

Taiko Pharmaceutical Co.,Ltd. (TSE:4574) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 08
Taiko Pharmaceutical Co.,Ltd. (TSE:4574) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Revenue & Expenses Breakdown
Beta

How Taiko PharmaceuticalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:4574 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 236,120-3,6113,5830
30 Sep 236,068-2,2753,1660
30 Jun 235,671-2,6113,3640
31 Mar 235,586-3,3903,7550
31 Dec 225,040-4,8954,1570
30 Sep 226,333-10,8295,5150
30 Jun 228,050-10,0206,1710
31 Mar 228,649-11,1956,6280
31 Dec 2111,299-9,5947,6940
31 Dec 2022,4564,1789,2670
30 Sep 2021,5484,6708,0630
30 Jun 2019,3234,2207,1910
31 Mar 2014,9662,4536,7530
31 Dec 1913,3222,2556,1000
30 Sep 1910,9781,6085,2690
30 Jun 1910,5691,4805,1630
31 Mar 1910,4181,4155,1310
31 Dec 189,9341,2274,8940
30 Sep 189,6501,2664,7360
30 Jun 189,3271,0334,7310
31 Mar 189,4591,0944,6950
31 Dec 178,9499514,4760
30 Sep 178,9481,0714,3960
30 Jun 178,6511,1834,1030
31 Mar 178,2941,0494,0250
31 Dec 168,2861,3173,8380
30 Sep 168,0699714,0520
30 Jun 167,9387554,2800
31 Mar 168,3278404,3910
31 Dec 157,8707404,5170
30 Sep 158,5651,1914,4710
30 Jun 158,9541,5494,4200
31 Mar 158,9781,7704,3230
31 Dec 149,3091,6334,7210
30 Sep 149,3551,3334,7680
30 Jun 149,4481,4894,5980
31 Mar 149,9471,7474,5930
31 Dec 139,4531,7084,2520
30 Sep 138,3851,6943,8900
30 Jun 137,9841,4013,9280

Quality Earnings: 4574 is currently unprofitable.

Growing Profit Margin: 4574 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4574 is unprofitable, and losses have increased over the past 5 years at a rate of 44.7% per year.

Accelerating Growth: Unable to compare 4574's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4574 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.1%).


Return on Equity

High ROE: 4574 has a negative Return on Equity (-53.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.